World looks to spring for virus relief as vaccinations start hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
“The numbers of deaths should start to decrease slowly as the number vaccinated increases,” said Graham Medley, a professor of infectious disease modeling at the London School of Hygiene and Tropical Medicine and a member of the U.K. government’s COVID-19 advisory panel. But “if the vaccines do not stop transmission, then we will not see the numbers of infections change much.”
With more than 310,000 deaths from COVID-19, the U.S. has the most fatalities. Infections in the U.S. have topped 17 million, with more than a million new cases occurring in the past week alone.
Across Europe, nearly 376,000 people have died from COVID-19, according to the latest weekly figures from the European Centre for Disease Prevention and Control, with Italy and the U.K. suffering the most fatalities. The delay from the EU in approving the first vaccine has led to frustration from some corners, particularly in Germany, where the leading Pfizer Inc. and BioNTech SE shot was pioneered.
World looks to spring for coronavirus relief as vaccinations start
A droplet falls from a syringe after a health care worker is injected with the Pfizer-BioNTech COVID-19 vaccine.
(AP)
With more than 310,000 deaths from Covid-19, the U.S. has the most fatalities
As many as three vaccines could be available in the West by year-end, leaving governments and scientists hopeful the pandemic could start to turn a corner in the first half of 2021
Share Via
Read Full Story
The developed world could start to emerge from the deadly grip of the pandemic by late spring if the first wave of Covid-19 vaccines are deployed effectively, scientists say. Even so, infection rates are likely to remain high for some time.
THIS article follows on from my original piece in
The Conservative Woman last week which discussed a large number of concerns which I have with the precipitous UK rollout of the Pfizer vaccine. This follow-up stands on its own, but is best read after the first article.
Pfizer have no idea if the vaccine can prevent symptoms or transmission
I wrote in my original article that ‘the trials for this vaccine . . . were not designed to test if the vaccine can reduce severe COVID-19 symptoms, ie hospital admissions ICU admission or death. The trials were also not designed to test if the vaccine can interrupt transmission.’